Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Molecular Pharmacology
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Molecular Pharmacology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit molpharm on Facebook
  • Follow molpharm on Twitter
  • Follow molpharm on LinkedIn
Research ArticleArticle

Transient Receptor Potential Vanilloid-1 (TRPV1) Is a Mediator of Lung Toxicity for Coal Fly Ash Particulate Material

Cassandra E. Deering-Rice, Mark E. Johansen, Jessica K. Roberts, Karen C. Thomas, Erin G. Romero, Jeewoo Lee, Garold S. Yost, John M. Veranth and Christopher A. Reilly
Molecular Pharmacology March 2012, 81 (3) 411-419; DOI: https://doi.org/10.1124/mol.111.076067
Cassandra E. Deering-Rice
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mark E. Johansen
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jessica K. Roberts
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Karen C. Thomas
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Erin G. Romero
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jeewoo Lee
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Garold S. Yost
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
John M. Veranth
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Christopher A. Reilly
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF
Loading

Abstract

Environmental particulate matter (PM) pollutants adversely affect human health, but the molecular basis is poorly understood. The ion channel transient receptor potential vanilloid-1 (TRPV1) has been implicated as a sensor for environmental PM and a mediator of adverse events in the respiratory tract. The objectives of this study were to determine whether TRPV1 can distinguish chemically and physically unique PM that represents important sources of air pollution; to elucidate the molecular basis of TRPV1 activation by PM; and to ascertain the contributions of TRPV1 to human lung cell and mouse lung tissue responses exposed to an insoluble PM agonist, coal fly ash (CFA1). The major findings of this study are that TRPV1 is activated by some, but not all of the prototype PM materials evaluated, with rank-ordered responses of CFA1 > diesel exhaust PM > crystalline silica; TRP melastatin-8 is also robustly activated by CFA1, whereas other TRP channels expressed by airway sensory neurons and lung epithelial cells that may also be activated by CFA1, including TRPs ankyrin 1 (A1), canonical 4α (C4α), M2, V2, V3, and V4, were either slightly (TRPA1) or not activated by CFA1; activation of TRPV1 by CFA1 occurs via cell surface interactions between the solid components of CFA1 and specific amino acid residues of TRPV1 that are localized in the putative pore-loop region; and activation of TRPV1 by CFA1 is not exclusive in mouse lungs but represents a pathway by which CFA1 affects the expression of selected genes in lung epithelial cells and airway tissue.

Footnotes

  • This work was supported by grants from the National Institutes of Health National Institute of Environmental Health Sciences [Grant ES017431], and the 2011 Colgate-Palmolive Postdoctoral Fellowship (to C.E.D.-R.). Development and synthesis of LJO-328 was supported by the National Research Foundation of Korea [R11-2007-107-02001-0] (to J.L.).

  • Article, publication date, and citation information can be found at http://molpharm.aspetjournals.org.

    http://dx.doi.org/10.1124/mol.111.076067.

  • ABBREVIATIONS:

    PM
    particulate matter
    TRPA1
    transient receptor potential ankyrin-1
    TRPM8
    transient receptor potential melastatin-8
    TRPC4α
    transient receptor potential canonical-4, α variant
    TRPV1
    transient receptor potential vanilloid-1
    TRPV2
    transient receptor potential vanilloid-2
    TRPV3
    transient receptor potential vanilloid-3
    TRPV4
    transient receptor potential vanilloid-4
    IL
    interleukin
    AITC
    allyl isothiocyanate
    GSK1016790A
    N-(1-((4-(2-(((2,4-dichlorophenyl)sulfonyl)amino)-3-hydroxypropanoyl)-1-piperazinyl)carbonyl)-3-methylbutyl)-1-benzothiophene-2-carboxamide
    LJO-328
    N-(4-tert-butylbenzyl)-N′-(1-[3-fluoro-4-(methylsulfonylamino)phenyl]ethyl)thiourea
    BEAS-2B
    human bronchial epithelial cells
    NHBE
    normal human bronchial epithelial cells
    LHC-9
    Lechner and LaVeck media
    CFA1
    power plant coal fly ash
    CFA2
    laboratory-generated-coal fly ash
    DEP
    diesel exhaust particles
    MUS
    Min-U-Sil 5 μM, crystalline silica
    DD
    desert dust particulate
    HEK
    human embryonic kidney
    TRPV1-OE
    TRPV1-overexpressing BEAS-2B cells
    PBS
    phosphate-buffered saline
    PBS-T
    PBS/Tween 20
    PCR
    polymerase chain reaction
    qPCR
    quantitative real-time PCR
    GAPDH
    glyceraldehyde-3-phosphate dehydrogenase
    GADD153
    growth arrest and DNA damage induced gene-153
    MIP
    macrophage inflammatory protein
    ANOVA
    analysis of variance.

  • Received September 23, 2011.
  • Accepted December 8, 2011.
  • Copyright © 2012 The American Society for Pharmacology and Experimental Therapeutics
View Full Text

MolPharm articles become freely available 12 months after publication, and remain freely available for 5 years. 

Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page. 

 

  • Click here for information on institutional subscriptions.
  • Click here for information on individual ASPET membership.

 

Log in using your username and password

Forgot your user name or password?

Purchase access

You may purchase access to this article. This will require you to create an account if you don't already have one.
PreviousNext
Back to top

In this issue

Molecular Pharmacology: 81 (3)
Molecular Pharmacology
Vol. 81, Issue 3
1 Mar 2012
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Editorial Board (PDF)
  • Front Matter (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Molecular Pharmacology article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Transient Receptor Potential Vanilloid-1 (TRPV1) Is a Mediator of Lung Toxicity for Coal Fly Ash Particulate Material
(Your Name) has forwarded a page to you from Molecular Pharmacology
(Your Name) thought you would be interested in this article in Molecular Pharmacology.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Research ArticleArticle

Activation of TRPV1 by Particulate Material

Cassandra E. Deering-Rice, Mark E. Johansen, Jessica K. Roberts, Karen C. Thomas, Erin G. Romero, Jeewoo Lee, Garold S. Yost, John M. Veranth and Christopher A. Reilly
Molecular Pharmacology March 1, 2012, 81 (3) 411-419; DOI: https://doi.org/10.1124/mol.111.076067

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Research ArticleArticle

Activation of TRPV1 by Particulate Material

Cassandra E. Deering-Rice, Mark E. Johansen, Jessica K. Roberts, Karen C. Thomas, Erin G. Romero, Jeewoo Lee, Garold S. Yost, John M. Veranth and Christopher A. Reilly
Molecular Pharmacology March 1, 2012, 81 (3) 411-419; DOI: https://doi.org/10.1124/mol.111.076067
Reddit logo Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Introduction
    • Materials and Methods
    • Results
    • Discussion
    • Authorship Contributions
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Mechanism of the selective action of paraherquamide A
  • Use-Dependent Relief of A-887826 Inhibition
  • Benzbromarone Relaxes Airway Smooth Muscle via BK Activation
Show more Articles

Similar Articles

Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About Molecular Pharmacology
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Journal of Pharmacology and Experimental Therapeutics
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0111 (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics